Details for Patent: 12,097,285
✉ Email this page to a colleague
Which drugs does patent 12,097,285 protect, and when does it expire?
Patent 12,097,285 protects MYHIBBIN and is included in one NDA.
This patent has four patent family members in three countries.
Drugs Protected by US Patent 12,097,285
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Azurity | MYHIBBIN | mycophenolate mofetil | SUSPENSION;ORAL | 216482-001 | May 1, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | PROPHYLAXIS OF ORGAN REJECTION | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,097,285
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3836898 | ⤷ Sign Up | |||
| United Kingdom | 202103764 | ⤷ Sign Up | |||
| United Kingdom | 2591396 | ⤷ Sign Up | |||
| World Intellectual Property Organization (WIPO) | 2020039263 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
